BioCardia Announces Upcoming Cell Therapy Presentations At Cardiovascular Research Technologies Conference
SAN CARLOS, Calif.--(BUSINESS WIRE)--BioCardia®, Inc., a leader in cardiovascular regenerative medicine, announces today two presentations related to the Company’s autologous bone marrow derived cell therapy in settings of post-acute infarction and heart failure at the Cardiovascular Research Technologies (CRT 2016) meeting in Washington DC.